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Abstract
Objective: Positive affect (PA) is closely linked to prevention of, and recovery from, depression. Previous studies
have investigated PA reactivity to pleasant situations with respect to its protective properties in relation to mood
disorder. The purpose of this study was to examine, and replicate, whether moment-to-moment transfer of PA in daily
life (PA persistence) is relevant to the prediction of future course of depression.
Method: Individuals from three different studies (one general population sample (n=540), and two patient samples
(n=43 and n=50) with matching controls (n=39 and n=21, respectively)) participated in an Experience Sampling
Method (ESM) study. Time-lagged multilevel analyses were used to assess the degree of transfer (or persistence) of
momentary positive affective states over time, in relation to naturalistic outcome (study 1) or treatment outcome
(studies 2 and 3). Depressive symptoms were measured using the Symptom Checklist (SCL-90R) in sample 1 and
the Hamilton Depression Rating Scale (HDRS) in samples 2 and 3.
Results: In study 1, participants with greater momentary PA persistence were less likely to show depressive
symptoms at follow-up. In study 2, patients were more likely to respond to treatment if they displayed greater
momentary PA persistence, particularly in those with recurrent depression. In study 3, patients with greater
momentary PA persistence were similarly more likely to respond to treatment, especially when treated with
imipramine rather than placebo.
Conclusion: The ability to transfer PA from one moment to the next is an important factor in the prevention of and
recovery from depressive symptoms. Patients with recurrent depression and those who receive antidepressants
rather than placebo may benefit most from this effect. The results suggest that treatment-induced improvement in
depression is mediated by increased levels of momentary transfer of PA in daily life, acquisition of which may be
contingent on duration of exposure to depressive experience.
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Introduction
There is considerable evidence showing that being able to
experience positive affect (PA) has beneficial effects on mental
health, particularly in depression. Studies have shown that PA
works by undoing the effects of stress [1-5]. In addition,
experience of PA decreases the likelihood of follow-up
depressive symptoms [2,3,6], and facilitates remission from a
depressive episode [7-10].
Positive and negative affective states do not represent two
extremes of the same dimension [11]. Rather, they constitute
distinct dimensions of emotional experience, with distinct
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adaptive functions, mediation of which takes place in different
brain systems [12,13]. Where negative affect (NA) may inform
the person of imminent threat (with respect to life, future, or
hierarchical position in the group), PA has the function of
engaging the person with the environment and other individuals
in social networks [13,14]. This function is reflected in the fact
that positive affective states have an inverted U-shaped curve
over the day [15], suggesting that most PA is experienced in
the middle of the day when there are more opportunities to
encounter pleasant situations. The broaden-and-build theory
[14] suggests that positive emotions have a direct impact on
attentional awareness, making us more open to experience
and contact. This theory also suggests that positive emotions
facilitate the building of social networks, resulting in long-term
well-being and social connectedness. Garland and colleagues
[16] characterized this as the positive spiral of positive
emotions: increased social openness and positive behavioral
repertoire will, in turn, again lead to new experiences of
positive emotions. Taken together, PA appears to significantly
contribute to mental health.
There are different ways to acquire PA. One is the
experience of PA in response to natural rewards. Reactivity to
rewarding situations has been examined both experimentally
and prospectively in the flow of daily life. Experimental studies
expose individuals to pleasant images in the laboratory or use
computer tasks in which participants can earn certain monetary
rewards [17-20]. Other studies prospectively measured
appraisals of situations and affective states, and examined
reactivity to pleasant situations in the flow of daily life
[2,8,9,21,22].
Second, retention of earlier acquired PA contributes to
subsequent positive emotional experience over time. Only few
studies have tried to examine this phenomenon in relation to
depressive symptoms. Heller and colleagues [23] found that
depressed patients have difficulty sustaining activity in brain
areas that are responsible for PA and reward, suggesting
reduced PA persistence in depression. Two other experimental
studies measured persistence of PA and NA in the laboratory,
during a 20-minute family interaction task between adolescents
and their parents, focused at resolving an area of conflict. The
conversations were videotaped and emotional fluctuations
were measured by rating the verbal and non-verbal behavior of
healthy and depressed adolescents during this interaction.
Results showed that, compared to healthy participants,
depressed adolescents were more emotionally resistant; that
is, showed less emotional reactivity to changing circumstances
[24]. In healthy adolescents, this emotional resistance to both
positive and negative change predicted follow-up onset of
major depression [25]. To date, only one study has measured
persistence of PA in daily life. This study compared the extent
to which individuals retained PA over time in a group of 53
depressed adults compared to a group of 53 healthy controls
[26]. No differences between groups were found.
Taken together, only few studies have prospectively
examined PA persistence in relation to depression. These
studies used different designs and yielded dissimilar
conclusions. There is an urgent need for replication of findings
as true replication of studies across different designs is
challenging. Therefore, in the present study we explored PA
persistence in three different samples by examining moment-
to-moment transfer of positive affect in the flow of real life.
Studies that measure PA persistence prospectively in the flow
of daily life are particularly scarce. To our knowledge, to date
no study has examined prospectively, in the flow of daily life,
how PA persistence –conceptualized as moment-to-moment
transfer of PA- predicts future course of depression. For this
purpose, we used the Experience Sampling Method (ESM)
[27-30].
ESM is an assessment technique that allows prospective
tracking of momentary experience in daily life. The advantage
of this technique is that subtle moment-to-moment transitions in
affective states are captured and assessed in the moment, with
minimal retrospection and cognitive reinterpretation.
Furthermore, ESM has strong ecological validity, as
measurements are performed in everyday life [31].
The aim of this study was to examine and replicate, in three
different samples, whether moment-to-moment transfer of PA
predicts future course of depressive symptoms. First, we
examined in a general female population sample whether
moment-to-moment transfer of PA would be associated with
follow-up symptoms of depression. Second, we examined in a
sample of depressed patients whether differences in moment-
to-moment transfer of PA would be associated with differences
in treatment response. In addition, in this sample we were able
to examine whether this effect would differ for patients with first
episode versus recurrent depression, as previous work
suggests that this is an important moderator of treatment
response [32]. Finally, in a third sample we investigated again
whether differences in moment-to-moment transfer of PA would
be associated with differences in treatment response in
depressed patients. The data of this sample, however, were
derived from a randomized controlled trial in which depressed
participants were allocated to imipramine or placebo treatment.
Therefore, this sample allowed for an additional moderation
analysis comparing active pharmacological treatment with
placebo. For both patient samples, matched healthy controls
were available to additionally compare effects as a function of
clinical status.
Methods
Three separate studies were carried out to answer the above
research questions. For a graphical overview of the design and
research questions of each study, see Figure 1. The same
ESM was employed across the three studies.
Ethics statement
Study 1 was approved by the Committee of Medical Ethics of
the University of Leuven, Belgium. Studies 2 and 3 were
approved by the Medisch-Ethische Toetsingscommissie of the
Academic Hospital in Maastricht/Maastricht University (METC
azM/UM), the Netherlands. All participants provided written
informed consent.
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Figure 1.  Schematic plan of analyses for study 1, 2, and 3.  Effect of momentary transfer of positive affect (PA) from (t-1) to (t)
approximately 90 minutes later, moderated by (1) follow-up depressive symptoms, defined by mean SCL-90R score at four follow-
up assessments spread over 14 months, (2) response to treatment with imipramine/placebo, defined by HDRS score after six
weeks, and (3) response to treatment at first episode/recurrent depression, defined by HDRS score over eight weeks.
doi: 10.1371/journal.pone.0075655.g001
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Experience sampling method
ESM is a structured diary technique to assess individuals in
their daily living environment; it has been extensively validated
for the use of momentary affect measurements [27,29,30]. In
the present three studies, participants received a digital
wristwatch and a set of ESM self-assessment forms collated in
a booklet for each day. The wristwatch was programmed to
emit a signal (‘beep’) at an unpredictable moment in each of
ten 90-min time blocks between 07:30 and 22:30, on five or six
consecutive days, depending on the study. After each beep,
participants were asked to fill out the ESM self-assessment
forms, collecting reports of mood. All self-assessments were
rated on seven-point Likert scales. Trained research assistants
with ample experience in momentary assessment techniques
explained the ESM procedure to the participants during an
initial briefing session and a practice form was completed to
confirm that all were able to understand the scales. Subjects
could call a telephone number in case they had questions or
problems during the ESM sampling period. Participants were
instructed to complete their reports immediately after the beep,
thus minimizing memory distortion, and to record the time at
which they completed the form. In order to verify compliance,
the reported completion time was compared with the actual
time of the beep. All reports not filled in within 15 minutes after
the beep were excluded from the analysis, as previous work
has shown that reports completed after this interval are less
reliable and consequently less valid [27]. In addition,
participants with fewer than 17 out of 50 (study 1), or 20 out of
60 (studies 2 and 3) valid reports were excluded from the
analysis, as previous work has shown that measures of
individuals with less than 30% of completed reports are less
reliable [27].
Study 1
Participants
We investigated in a sample of 621 participants from the
East-Flanders Prospective Twin Survey in Belgium –a general
population sample that has been followed prospectively to
study gene–environment interactions in affective disorders [33]-
whether people with greater momentary transfer of PA are less
likely to develop follow-up depressive symptoms. Although
most subjects were twins, the current study did not require twin
methodology.
Of the 621 participants, 610 completed the ESM
measurements. Thirty-one were subsequently excluded due to
inadequate ESM compliance and 39 due to missing follow-up
data on depressive symptoms, resulting in a final sample of
540 participants. The mean number of completed ESM reports
was 38.0 (SD 6.6; range 17-50). Participants were white and of
Belgian origin; mean age was 27.6 (SD 7.8; range 18-61).
Thirty-four percent of participants were married, 35% had
completed secondary education, and 63% had college or
university degrees. The majority (60%) was employed.
Study design
ESM took place at baseline (T0) for five consecutive days.
Depressive symptoms were assessed at (T0) and again at
each of the four follow-up assessments (T1-T4), conducted at
intervals of three to four months.
Measurements
Affective states.  PA was assessed at each beep during the
ESM procedure. Since some analyses had to be controlled for
level of NA, this was assessed in a similar fashion as PA.
Participants rated ten momentary affective states on 7-point
Likert scales (1: not at all to 7: very). Our choice of the ESM
affect items was guided by the PANAS questionnaire [34] and
by results of previous ESM studies (selecting items with high
loadings on NA and PA latent factors and sufficient within-
person variability). Factor analysis, using principal component
analysis with oblique rotation, identified two mood factors with
eigenvalue >1 [8]. Ratings for the items ‘cheerful’, ‘content’,
‘energetic’, and ‘enthusiastic’ –weighted for factor loadings-
were averaged to form the PA scale. The weighted average of
ratings for ‘insecure’, ‘lonely’, ‘anxious’, ‘low’, ‘guilty’, and
‘suspicious’ formed the NA scale.
Depressive symptoms.  All participants completed the
Symptom Checklist (SCL-90R) [35], which yielded prospective
measures of depressive symptoms over time. As a measure of
follow-up depressive symptomatology, we used the mean of
the SCL-90R scores over time points T1 through T4. In order to
improve normality, the SCL-90R depression score was log-
transformed.
Statistical analysis
ESM data have a hierarchical structure with multiple
observations (level 1) clustered within participants (level 2).
Multilevel analysis takes the variability associated with each
level of nesting into account [36]. Multilevel mixed regression
analyses, using the xtmixed command in Stata 11.1
(StataCorp, 2009), were applied to the data. To obtain a
regression model that specifically tests within-subject effects,
we centered the variables PA and NA around the individual
mean. The model estimated the extent to which PA level at
moment (t-1) (independent variable) predicted PA level at the
next moment (t), approximately 90 minutes later on the same
day (dependent variable), reflecting the degree of momentary
PA transfer or PA persistence. By fitting an interaction term
between PA at (t-1) and mean SCL-90R scores at T1-T4 in the
model of PA at (t), we tested whether PA persistence differed
according to level of depressive symptoms at follow-up,
corrected for baseline depressive symptoms (Figure 1). This
model thus effectively tests whether the association between
baseline PA and follow-up SCL-90R scores is contingent on
the level of PA persistence. We controlled for level of NA at
moment (t) to ensure that any effect of momentary transfer of
PA was in fact independent from level of NA. All effect sizes
were standardized and calculated from the model containing
the interaction with the Stata lincom command.
Results
Overall, level of PA at a given beep was a significant
predictor of level of PA at the next beep (β=.370, SE=.007, p<.
001). Furthermore, in the model of PA at (t) at baseline, there
was a significant negative interaction between PA at (t-1) and
Transfer of Positive Emotions Predicts Depression
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level of follow-up depressive symptoms (β interaction=-.015,
SE=.007, p<.05). Participants with greater momentary transfer
of PA showed lower levels of depressive symptoms at follow-
up. A dose-response association was apparent. Standardized
effect sizes, stratified by the tertile groups of follow-up
depressive symptoms are displayed in Figure 2.
Study 2
Participants
The second sample consisted of 47 depressed patients
recruited at a university-affiliated outpatient mental health
center in Maastricht, the Netherlands [37]. Inclusion criteria
were a DSM-IV diagnosis of major depressive disorder (MDD),
age between 18 and 65 years, and a baseline score of ≥18 on
the 17-item Hamilton Depression Rating Scale (HDRS) [38].
Exclusion criteria included bipolar disorder, substance abuse,
psychotic symptoms, and insufficient Dutch language
proficiency. Moreover, none of the participants was taking
antidepressants or other psychotropic medication, other than
low dose benzodiazepines. Fifty-five healthy participants,
matched as a group to the patient sample for sex and age,
were recruited from available research pools and
advertisements in a local newspaper. Additional exclusion
criteria for the healthy participants were a lifetime history of any
DSM-IV Axis I disorder or any inpatient treatment for an Axis I
psychiatric disorder in a first-degree relative. Participants who
completed the study received a 30 euro gift certificate.
In the patient group, one participant was excluded due to
insufficient valid ESM reports, and three patients had missing
HDRS scores. Of 55 potential controls who were screened, 16
did not meet the inclusion criteria. The mean number of
completed ESM reports was 49.6 (SD 7.7; range 20-60). The
final sample consisted of 82 participants: 43 depressed and 39
matched healthy participants (Table 1). The 25 patients who
were depressed for the first time were categorized as first
episode patients, of which 12 were classified as responders to
treatment. The 18 patients with one or more prior episodes of
depression were categorized as recurrent episode patients, of
which nine were classified as responders to treatment.
Study design
All participants (including the healthy controls) underwent
ESM at baseline for six consecutive days. Immediately after the
ESM sampling week, the depressed patients entered a
naturalistic treatment phase (as described in [39]), during which
they received a combination of pharmacotherapy and
supportive psychotherapy. MDD treatment was administered
according to standard guidelines [40]. Typically, sessions were
weekly and decreased in frequency following agreement
between therapist and participant. Therapies at the treatment
center typically lasted between 15 and 20 therapy sessions.
Participants were prescribed serotonergic antidepressants in
flexible dosage depending on participants’ response and
Table 1. Demographic data for depressed patients and
healthy controls.
 Depressed patients Healthy controls
N 43 39
% women 58 58
Mean age (SD) 39.8 (11.1) 44.3 (11.6)
- range 20-58 22-62
% married 86 59
% secondary education 56 89
% employed 37 79
SD = standard deviation
doi: 10.1371/journal.pone.0075655.t001
Figure 2.  Degree of momentary PA persistence at baseline as a function of follow-up depressive symptom severity.  Bars
represent the association between PA at (t-1) and PA at (t) (level of momentary transfer of positive affect (PA) from (t-1) to (t)
approximately 90 minutes, or level of PA persistence), stratified by SCL-90R severity level. Error bars represent one standard error
of the mean.
doi: 10.1371/journal.pone.0075655.g002
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tolerance. In case of non-response, medication was switched
to venlafaxine or a tricyclic agent, and lithium was added in
case of enduring non-response. No participants received MAO
inhibitors or electroconvulsive therapy (ECT). In order to
assess the course of depression, the HDRS was administered
at screening and thereafter at baseline, week four, and week
eight.
Measurements
Affective states.  The ESM affect items were selected
according to the method described in study 1. Factor analysis,
using principal component analysis with oblique rotation,
identified two mood factors with eigenvalue >1 [41]. Ratings on
the items ‘enthusiastic’, ‘happy’, ‘cheerful’, ‘strong’, and
‘satisfied’ –weighted for factor loadings- were averaged to form
a PA scale. Ratings on the items ‘anxious’, ‘irritated’, ‘harried’,
‘tense’, ‘lonely’, ‘gloomy’, ‘guilty’, ‘edgy’, ‘insecure’, and ‘tired’
were averaged to form an NA scale.
Depressive symptoms.  Clinical outcome was measured
with the HDRS [38]. A trained research assistant conducted the
assessments during telephone interviews. A random sample of
16 interviews was simultaneously rated by an experienced
psychiatrist in order to check the quality of assessments and
avoid ‘drift’.
Statistical analysis
In order to categorize treatment response, change in HDRS
scores was dichotomized. Patients with the 50% largest
decrease in HDRS score were classified as responders, and
the remaining 50% were classified as non-responders.
Response was assessed eight weeks after the start of
treatment. We created one group status variable defining
healthy controls, non-responders, and responders. A second
group status variable was created including separate
categories for healthy controls, first episode non-responders,
first episode responders, recurrent episode non-responders,
and recurrent episode responders. Centering and multilevel
regression analyses were performed as in study 1. We
examined by multilevel regression analysis whether momentary
PA level at (t-1) (independent variable) predicted momentary
PA level at (t) (dependent variable). An interaction was fitted
between PA at (t-1) and the three level group status variable
(healthy controls, non-responders, and responders), in order to
examine whether the transfer of PA from (t-1) to (t) differed
between healthy controls, patients who did, and patients who
did not respond to treatment (Figure 1). Furthermore, we
analyzed whether momentary transfer of PA differed between
patients with a first episode and patients with recurrent
depression by fitting an interaction between PA at (t-1) and the
five-level group status variable (healthy controls, first episode
non-responders, first episode responders, recurrent episode
non-responders, and recurrent episode responders). As in
study 1, analyses were corrected for level of NA and all effect
sizes were standardized.
Results
Level of PA at beep (t-1) significantly predicted level of PA at
the following beep (β=.446, SE=.015, p<.001). Non-responders
showed less transfer of momentary PA at baseline than healthy
controls (β interaction=-.090, SE=.043, p<.05). Responders
showed greater transfer of momentary PA when compared to
non-responders (β interaction=.105, SE=.048, p<.05), and did
not differ from healthy controls.
Examining the effect of first episode versus recurrent
depression status on transfer of momentary PA revealed the
following results (Table 2): Compared to healthy controls, first
episode non-responders showed significantly less transfer of
momentary PA, while recurrent episode responders showed
significantly greater transfer of momentary PA. Other groups
did not significantly differ from healthy controls. Compared to
first episode non-responders, all other groups of depressed
patients had significantly greater transfer of momentary PA.
Standardized effect sizes per group are displayed in Figure 3.
Study 3
Participants
A sample of 83 patients was recruited in eight primary care
practices in the Netherlands to participate in a randomized
controlled trial (RCT) examining the effects of imipramine
compared to placebo on daily quality of life. Inclusion criteria
were a DSM-IV diagnosis of current major depressive disorder,
age between 18 and 65 years, a baseline score of ≥18 on the
17-item HDRS, and a score of ≥4 on the Clinical Global
Impression scale (CGI) [42]. Patients with major somatic
complaints or using psychotropic medications, except for the
occasional use of temazepam, were excluded. Furthermore, 29
healthy participants were recruited in primary care practices to
provide normal reference values for ESM measures. This
comparison group was matched to the depressed group in
Table 2. PA persistence (association between PA(t-1) and
PA(t)) in study 2, stratified by responder/non-responder and
first/recurrent subgroup.
Reference group  β SE p-value
Healthy controls First episode non-responders -.203 .055 <.001
 Recurrent episode non-responders .034 .057 .55
 First episode responders -.044 .043 .31
 Recurrent episode responders .139 .060 .02
First episode non-
responders
Recurrent episode non-
responders .237 .074 .001
 First episode responders .159 .063 .01
 Recurrent episode responders .342 .075 <.001
Recurrent episode non-
responders First episode responders -.078 .065 .23
 Recurrent episode responders .105 .077 .17
First episode
responders Recurrent episode responders .183 .067 .007
β = effect size of PA(t-1) on PA(t), moderated by group status; SE = standard
error.
doi: 10.1371/journal.pone.0075655.t002
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terms of age, sex distribution, and socioeconomic status (for
details, see [43]).
In the patient group 12 were excluded because they did not
meet the inclusion criteria, six patients provided less than 30%
valid ESM reports, one patient had a missing baseline HDRS
score, and 14 patients had missing follow-up HDRS scores. Of
29 screened controls, six were excluded due to lifetime
depression or current psychiatric illness, and two participants
provided less than 30% valid ESM reports. The mean number
of completed ESM reports was 47.1 (SD 7.6; range 21-59). The
final sample consisted of 71 participants: 50 patients and 21
healthy controls (Table 3). There were 23 patients in the
imipramine group, of which 14 were classified as responders to
treatment. There were 27 patients in the placebo group, of
which 9 were classified as responders to treatment.
Study design
In a RCT procedure as described in [44], all participants
(including the control group) underwent ESM at baseline for six
consecutive days. During the initial baseline week, participants
received no treatment in any form. Thereafter, patients were
randomly assigned to twice daily, double-blind, 6-week
treatment with either imipramine (starting dose of 50 mg/day,
increased to 200 mg/day over the first week of treatment) or a
placebo (starting with one capsule per day, increased to four
capsules over the first week of treatment). In order to assess
the course of depression, the HDRS was administered at
baseline and at week six. The healthy controls served as
reference group and were not randomized to any treatment.
Measurements
Affective states.  The ESM affect items were selected
according to the procedure described in study 1. Factor
analysis, using principal component analysis with oblique
rotation, identified two mood factors with eigenvalue >1 [44].
Ratings on the items ‘content’, ‘enthusiastic’, ‘cheerful’, ‘strong’,
‘energetic’, ‘alert’, ‘calm’, and ‘happy’ –weighted for factor
loadings- were averaged to form a PA scale. Ratings on the
items ‘depressed’, ‘lonely’, ‘irritable’, ‘insecure’, ‘harried’,
‘anxious’, ‘guilty’, ‘hostile’, and ‘tensed’ were averaged to form
an NA scale.
Depressive symptoms.  The 17-item HDRS was
administered by the treating general practitioner (GP). All
participating GPs had completed a standardized training for the
HDRS procedure.
Table 3. Demographic data for depressed (imipramine/
placebo treatment) and healthy participants.
 
Depressed
(imipramine
treatment)
Depressed
(placebo
treatment)
Healthy
controls
N 23 27 21
%women 78 74 76
Mean age (SD) 42.6 (9.7) 42.3 (8.7) 42.0 (11.2)
- range 26-59 25-58 18-62
% married 86 59 83
% secondary education 65 73 64
% college/university 13 13 6
% employed 65 29 51
% homemaker 31 25 18
% in school 0 11 6
% unfitted for work/
unemployed 5 22 6
SD = standard deviation.
doi: 10.1371/journal.pone.0075655.t003
Figure 3.  Degree of momentary PA persistence as a function of treatment response, first/recurrent episode and healthy
control status.  Bars represent the association between PA at (t-1) and PA at (t) (level of momentary transfer of positive affect (PA)
from (t-1) to (t) approximately 90 minutes, or level of PA persistence), stratified by treatment response and first episode/recurrent
episode subgroups. Error bars represent one standard error of the mean.
doi: 10.1371/journal.pone.0075655.g003
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Statistical analysis
Responders and non-responders were classified as in study
2. Response was assessed six weeks after the start of
treatment. We created one group status variable defining
healthy controls, patient non-responders, and patient
responders. A second group status variable was created
including separate categories for healthy controls, imipramine
responders, imipramine non-responders, placebo responders,
and placebo non-responders. Centering and multilevel
regression analyses were performed as in studies 1 and 2. We
examined whether momentary PA level at (t-1) (independent
variable) predicted momentary PA level at (t) (dependent
variable). An interaction was fitted between PA at (t-1) and the
three-level group status variable (healthy controls, non-
responders, responders), in order to examine whether the
transfer of PA from (t-1) to (t) differed between healthy controls,
patients who did, and patients who did not respond to
treatment (Figure 1). Furthermore, we analyzed whether
momentary transfer of PA differed between patients who
received imipramine and patients who received a placebo by
fitting an interaction between PA at (t-1) and the five-level
group status variable (healthy controls, imipramine responders,
imipramine non-responders, placebo responders, and placebo
non-responders). As in the previous two studies, analyses were
corrected for level of NA and all effect sizes were standardized.
Results
Level of PA at any beep significantly predicted level of PA at
the next beep (β=.517, SE=.016, p<.001). This association was
significantly different for responders, non-responders, and
healthy controls. More specifically, non-responders showed
less momentary transfer of PA at baseline than healthy controls
(β interaction=-.143, SE=.042, p<.001). Responders, however,
had higher levels of momentary transfer of PA than healthy
controls (β interaction=.118, SE=.043, p<.01).
Examining the effect of type of treatment (imipramine/
placebo) revealed that responders in the imipramine group had
significantly greater momentary transfer of PA at baseline than
placebo responders or imipramine and placebo non-
responders (Table 4). Standardized effect sizes per group are
displayed in Figure 4.
Table 4. PA persistence (association between PA(t-1) and
PA(t)) in study 3, stratified by responder/non-responder and
placebo/imipramine subgroup.
Reference group  β SE p-value
Healthy controls Placebo non-responders -.168 .044 <.001
 Imipramine non-responders -.140 .069 .04
 Placebo responders .043 .056 .44
 Imipramine responders .170 .052 .001
Placebo non-responders Imipramine non-responders .028 .070 .69
 Placebo responders .212 .057 <.001
 Imipramine responders .338 .053 <.001
Placebo responders Imipramine non-responders -.183 .078 .02
 Imipramine responders .126 .063 .05
Imipramine non-responders Imipramine responders .310 .075 <.001
β = effect size of PA(t-1) on PA(t), moderated by group status; SE = standard
error.
doi: 10.1371/journal.pone.0075655.t004
Figure 4.  Degree of momentary PA persistence as a function of treatment response, placebo/imipramine and healthy
control treatment status.  Bars represent the association between PA at (t-1) and PA at (t) (level of momentary transfer of positive
affect (PA) from (t-1) to (t) approximately 90 minutes, or level of PA persistence), stratified by treatment response and placebo/
imipramine subgroups. Error bars represent one standard error of the mean.
doi: 10.1371/journal.pone.0075655.g004
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Discussion
This is the first study to show that the ability to savor PA over
time in daily life predicts future course of depressive symptoms
in both healthy and depressed individuals. This effect was
replicated, using the same methodology, across three
independent samples. We found that individuals from a general
population sample with a higher baseline ability to savor PA in
daily life had a lower level of depressive symptoms at follow-
up. In the first clinical sample, baseline transfer of PA over time
predicted response after eight weeks to combined treatment
with antidepressants and psychotherapy. This effect was more
pronounced in patients with a history of depressive episodes
than in patients who were depressed for the first time. Finally,
the results from the second clinical sample revealed that
baseline moment-to-moment transfer of PA over time predicted
treatment response after six weeks. Moreover, allocation to
imipramine rather than placebo was related to a stronger
association between moment-to-moment transfer of PA and
treatment response.
Consistent with prior research [2,3,6-10], our results
underscore the protective properties of PA against depression.
This study suggests that this protective mechanism is partly
mediated by the ability to savor PA in daily life.
Relation to previous findings regarding persistence of
positive affect
The days during which the focus of depression research was
solely on negative emotions have long passed. Contemporary
research seeks to determine to what extent positive emotions
are a factor in prevention and treatment of depressive illness
and whether they can predict the future course of the disorder
[2,3,6-10]. Although several studies have examined PA
reactivity to pleasant situations [2,8,9,19,22], PA persistence
remains understudied.
The current findings are compatible with work presented by
Heller and colleagues [23], who showed that depressed
patients have difficulty sustaining activity in brain areas
responsible for PA and reward. It is attractive to speculate that
these findings represent the neurobiological correlates of lower
level moment-to-moment transfer of PA in real life in depressed
patients, as reported in the current study. A recent ESM study
by Thompson and colleagues [26], however, found no
difference in momentary PA persistence between depressed
individuals and healthy controls. This contrasts with the current
findings, which indicated that generally lower PA persistence
was encountered in depressed patients as compared to healthy
controls. One potential difference between Thompson and
colleagues’ and our study to explain the discrepancy in findings
may be found in the group characteristics that were compared.
While Thompson and colleagues compared depressed patients
with healthy controls, our study mainly focuses on the
difference in response to treatment within the patient group as
compared to healthy controls. That is, we did not compare
healthy individuals with depressed patients in general, but with
responders and non-responders, respectively. Finally, a study
by Kuppens and colleagues [24] found that persistence of
happy feelings was related to higher levels of current and
future [25] depressive symptoms. In their experiment,
adolescents and their families were instructed to talk about
difficult family situations for 20 minutes while they were being
videotaped. The adolescents’ verbal and non-verbal behavior
during the interaction was rated, and happy, angry and
dysphoric behaviors were derived. The emotional behavior of
current and future depressed adolescents appeared to be more
resistant to changing circumstances. That is, they showed
greater persistence of positive as well as negative emotional
behavior than healthy participants. It is possible that these
contrasting findings reflect important differences in study
design and methodology. While we measured savoring PA in
daily life at random moments in the day, Kuppens and
colleagues measured the persistence over time in emotional
responses to a certain situation in the laboratory. A
fundamentally different concept may therefore have been
measured. Kuppens and colleagues explain their findings in
that a stronger persistence of PA or NA seems to indicate an
affective resistance to change, reflecting impaired adjustment
to the environment (emotional inertia) or inflexibility [25]. The
findings in the current study on moment-to-moment transfer of
PA pertained to measurements at a different time scale
(measurements were on average 90 minutes apart over
several days and were not assessed minute-to-minute in a 20
minute lab experiment) and do not reflect persistence of an
emotional response to a certain situation. Since measurements
in the current study were further apart than in the study of
Kuppens and colleagues [24,25], it is additionally possible that
in the current study a stronger persistence of PA reflected the
ability to use PA to create new PA in the near future. All in all,
the above differences in results and methodology highlight the
importance of within-study replication with constant
methodology.
Savoring positive affect as compensatory mechanism
The current study showed that increased transfer of PA over
time predicted better follow-up response to treatment in
patients. Particularly surprising was the fact that persistence of
PA over time was not only higher in responding versus non-
responding depressed patients, but also in responding
depressed patients versus healthy controls. Notably, increased
levels of PA persistence in depressed patient responders –
compared to controls- were found in both patient samples.
Better-than-normal ability to hold on to PA may be required for
depressed patients in order to recover. The differences in
depressed patients compared to healthy individuals are often
viewed upon as reflecting risk. However, the current findings
suggest that these specific alterations indicate a better than
average ability to savor PA. This extraordinary quality, or
resilience trait, may reflect a compensatory mechanism in that
increased ability to hold on to PA is required to counteract the
increased presence of NA in these individuals. A speculation is
that only in case of strong compensatory mechanisms, which
can restore emotional balance, patients will be able to recover.
Although responders generally appeared to be better at
savoring PA than non-responders, this effect was more
pronounced in patients with a history of depressive episodes
compared to patients who were depressed for the first time.
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This interesting finding raises the possibility that, due to the
recurrence of their depression, a learning process may have
taken place. Over time, patients with recurrent episodes may
have acquired ways to savor their PA, thereby aiding the
process of recovery [41]. However, these mechanisms need to
be examined in more depth before any firm conclusions can be
drawn.
The replication of the finding of higher PA persistence in
depressed patients who respond to treatment compared to
healthy controls in two independent samples underscores our
findings, and indicates that specific groups of depressed
patients paradoxically may possess higher-than-average ability
to preserve PA that can facilitate recovery.
Medication and savoring positive affect
Patients who responded to imipramine treatment showed
higher levels of PA persistence than responders who were
treated with a placebo. There are different ways to interpret this
finding. One potential interpretation is that antidepressant
medication acted synergistically with baseline ability to savor
PA in bringing about a reduction in depressive symptoms. This
interpretation suggests that medication may give an extra boost
to the favorable effect of baseline PA persistence on follow-up
outcome. An alternative interpretation is that for those using
imipramine a higher baseline PA persistence is required in
order to become a responder than for those using a placebo.
Although counterintuitive, there have been previous studies
suggesting that some antidepressants are associated with
‘emotional blunting’ [45,46], reduced reward experience [47],
and diminished processing of not only negative but also
positive stimuli [20]. In other words, the antidepressant may not
only diminish negative, but positive emotional experience as
well. Also, recent studies have shown that PA is important in
facilitating recovery from depression [7-10]. With respect to the
current findings this may suggest that patients who receive
antidepressants may need to be better at savoring PA in order
to counteract the PA-dampening effects of medication. This
interpretation is speculative, since the above studies all
employed SSRIs, whereas the patients in our study received a
tricyclic antidepressant (TCA). Further exploration of the long-
term underlying psychological effects of antidepressants is
needed in order to shed more light on the influence of
medication on PA.
Limitations
A limitation regarding study 1 is that the sample consisted of
female participants only. Consequently, our findings may not
generalize to men. A limitation regarding the patient samples
(studies 2 and 3) is that follow-up depressive symptoms were
not assessed at the exact same time point following baseline
measurements. That is, in study 2, depressive symptoms were
assessed eight weeks following the start of the treatment,
whereas in study 3, they were assessed after six weeks. It
should be noted as well that patients in study 2 were treated
with a combination of pharmacotherapy and supportive
psychotherapy, whereas in study 3 they received
pharmacotherapy only. Also, whereas in study 2
pharmacotherapy consisted mainly of serotonergic
antidepressants, in study 3 patients received TCAs. Despite
these differences in methodology, similar results were reported
regarding the effect of PA persistence on follow-up responder
status in both studies. Finally, a general limitation is that there
are some differences in the adjectives that were used to
conceptualize PA and NA in the three studies. This was a
consequence of the fact that we used existing ESM samples to
test our hypothesis. Slightly different choices for one item or
another were made by the researchers who conducted the
original studies. However, most items were identical and for
each study the items loaded on one factor of PA.
Conclusion
The present findings indicate that healthy individuals with
greater PA persistence have a significantly smaller probability
of developing increased levels of depressive symptoms, and
that depressed patients are more likely to respond to their
treatment if they have greater PA persistence at baseline. This
is the first study that, consistently and in three different
samples, indicates that PA persistence, as measured in the
flow of daily life, predicts future course of depressive
symptoms.
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